AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26

Authors: Morrison, WA Mitchell, GM Barker, JE Konopka, T Stewart, AG
Citation: Wa. Morrison et al., Angiogenesis in wound healing and surgery, NEW ANGIOTHERAPY, 2002, pp. 105-113

Authors: Barker, JE
Citation: Je. Barker, Elizabeth S. Russell 1913-2001 - Obituary, GENESIS, 31(1), 2001, pp. 54-56

Authors: Cosentino, F Barker, JE Brand, MP Heales, SJ Werner, ER Tippins, JR West, N Channon, KM Volpe, M Luscher, TF
Citation: F. Cosentino et al., Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice, ART THROM V, 21(4), 2001, pp. 496-502

Authors: Barker, JE Knight, KR Romeo, R Hurley, JV Morrison, WA Stewart, AG
Citation: Je. Barker et al., Targeted disruption of the nitric oxide synthase 2 gene protects against ischaemia/reperfusion injury to skeletal muscle, J PATHOLOGY, 194(1), 2001, pp. 109-115

Authors: Williams, MW Resneck, WG Kaysser, T Ursitti, JA Birkenmeier, CS Barker, JE Bloch, RJ
Citation: Mw. Williams et al., Na,K-ATPase in skeletal muscle: two populations of beta-spectrin control localization in the sarcolemma but not partitioning between the sarcolemma and the transverse tubules, J CELL SCI, 114(4), 2001, pp. 751-762

Authors: Konopka, TE Barker, JE Bamford, TL Guida, E Anderson, RL Stewart, AG
Citation: Te. Konopka et al., Nitric oxide synthase II gene disruption: Implications for tumor growth and vascular endothelial growth factor production, CANCER RES, 61(7), 2001, pp. 3182-3187

Authors: Kane, AJ Barker, JE Mitchell, GM Theile, DRB Romero, R Messina, A Wagh, M Fraulin, FOG Morrison, WA Stewart, AG
Citation: Aj. Kane et al., Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival, BR J PHARM, 132(8), 2001, pp. 1631-1638

Authors: Soper, BW Lessard, MD Vogler, CA Levy, B Beamer, WG Sly, WS Barker, JE
Citation: Bw. Soper et al., Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency, BLOOD, 97(5), 2001, pp. 1498-1504

Authors: Wandersee, NJ Roesch, AN Hamblen, NR de Moes, J van der Valk, MA Bronson, RT Gimm, JA Mohandas, N Demant, P Barker, JE
Citation: Nj. Wandersee et al., Defective spectrin integrity and neonatal thrombosis in the first mouse model for severe hereditary elliptocytosis, BLOOD, 97(2), 2001, pp. 543-550

Authors: Wandersee, NJ Lee, JC Deveau, SA Barker, JE
Citation: Nj. Wandersee et al., Reduced incidence of thrombosis in mice with hereditary spherocytosis following neonatal treatment with normal hematopoietic cells, BLOOD, 97(12), 2001, pp. 3972-3975

Authors: Beamer, WG Rosen, CJ Bronson, RT Gu, W Donahue, LR Baylink, DJ Richardson, CC Crawford, GC Barker, JE
Citation: Wg. Beamer et al., Spontaneous fracture (sfx): A mouse genetic model of defective peripubertal bone formation, BONE, 27(5), 2000, pp. 619-626

Authors: Sands, MS Barker, JE
Citation: Ms. Sands et Je. Barker, Untitled, COMPAR MED, 50(2), 2000, pp. 107-107

Authors: Wandersee, NJ Tait, JF Barker, JE
Citation: Nj. Wandersee et al., Erythroid phosphatidyl serine exposure is not predictive of thrombotic risk in mice with hemolytic anemia, BL CELL M D, 26(1), 2000, pp. 75-83

Authors: Barker, JE Deveau, S Wandersee, NJ
Citation: Je. Barker et al., Amelioration of severe hereditary spherocytosis in nonablated adult mice by marrow transplantation, EXP HEMATOL, 28(8), 2000, pp. 985-992

Authors: Dooner, GJ Barker, JE Gallagher, PG Debatis, ME Brown, AH Forget, BG Becker, PS
Citation: Gj. Dooner et al., Gene transfer to ankyrin-deficient bone marrow corrects spherocytosis in vitro, EXP HEMATOL, 28(7), 2000, pp. 765-774

Authors: Upadhya, P Birkenmeier, EH Birkenmeier, CS Barker, JE
Citation: P. Upadhya et al., Mutations in a NIMA-related kinase gene, Nek1, cause pleiotropic effects including a progressive polycystic kidney disease in mice, P NAS US, 97(1), 2000, pp. 217-221

Authors: Lazarus, B Messina, A Barker, JE Hurley, JV Romeo, R Morrison, WA Knight, KR
Citation: B. Lazarus et al., The role of mast cells in ischaemia-reperfusion injury in murine skeletal muscle, J PATHOLOGY, 191(4), 2000, pp. 443-448

Authors: Lam, J Takeshita, S Barker, JE Kanagawa, O Ross, FP Teitelbaum, SL
Citation: J. Lam et al., TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand, J CLIN INV, 106(12), 2000, pp. 1481-1488

Authors: Upadhya, P Churchill, G Birkenmeier, EH Barker, JE Frankel, WN
Citation: P. Upadhya et al., Genetic modifiers of polycystic kidney disease in intersubspecific KAT2J mutants, GENOMICS, 58(2), 1999, pp. 129-137

Authors: Barker, JE Kaysser-Kranich, TM Hamblen, N Deveau, S
Citation: Je. Barker et al., Multiple high cell dose injections of normal marrow into newborn jaundicedmice dramatically prolong life despite transient repopulation, EXP HEMATOL, 27(5), 1999, pp. 966-971

Authors: Soper, BW Duffy, TM Vogler, CA Barker, JE
Citation: Bw. Soper et al., A genetically myeloablated MPS VII model detects the expansion and curative properties of as few as 100 enriched murine stem cells, EXP HEMATOL, 27(11), 1999, pp. 1691-1704

Authors: Vogler, C Levy, B Galvin, NJ Thorpe, C Sands, MS Barker, JE Baty, J Birkenmeier, EH Sly, WS
Citation: C. Vogler et al., Enzyme replacement in murine mucopolysaccharidosis type VII: Neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy, PEDIAT RES, 45(6), 1999, pp. 838-844

Authors: Soper, BW Pung, AW Vogler, CA Grubb, JH Sly, WS Barker, JE
Citation: Bw. Soper et al., Enzyme replacement therapy improves reproductive performance in mucopolysaccharidosis type VII mice but does not prevent postnatal losses, PEDIAT RES, 45(2), 1999, pp. 180-186

Authors: Sands, MS Barker, JE
Citation: Ms. Sands et Je. Barker, Percutaneous intravenous injection in neonatal mice, LAB ANIM SC, 49(3), 1999, pp. 328-330

Authors: Stewart, AG Barker, JE Hickey, MJ
Citation: Ag. Stewart et al., Nitric oxide in ischaemia-reperfusion injury, ISCHAEMIA-REPERFUSION INJURY, 1999, pp. 180-195
Risultati: 1-25 | 26-26